MEDIFAST INC - Common Stock, $0.001 par value per share (MED)

Historical Holders from Q1 2014 to Q3 2025

Symbol
MED on NYSE
CUSIP
58470H101
Type / Class
Equity / Common Stock, $0.001 par value per share
Shares outstanding
10.9M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
9.25M
Holdings value
$126M
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
119
Number of buys
62
Number of sells
-41
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of MEDIFAST INC - Common Stock, $0.001 par value per share (MED)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
RENAISSANCE TECHNOLOGIES LLC 8.09% -12.3% $11.2M -$1.48M 889K -11.7% Renaissance Technologies LLC Jan 2, 2025
SUSQUEHANNA SECURITIES, LLC 6% -17.1% $8.95M -$1.79M 655K -16.6% G1 Execution Services, LLC Sep 30, 2025
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 5.41% $8.14M 595K CHARLES SCHWAB INVESTMENT MANAGEMENT INC Sep 30, 2025

Institutional Holders of MEDIFAST INC - Common Stock, $0.001 par value per share (MED)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 9.25M $126M +$8.38M $13.67 119
2025 Q2 8.62M $121M +$5.64M $14.05 119
2025 Q1 8.24M $111M -$12.3M $13.48 122
2024 Q4 8.92M $157M -$4.77M $17.62 129
2024 Q3 9.16M $175M -$26.8M $19.14 142
2024 Q2 10.4M $228M -$54M $21.82 159
2024 Q1 11.5M $440M +$31M $38.32 186
2023 Q4 10.3M $694M +$46.7M $67.22 214
2023 Q3 9.58M $718M -$16.2M $74.85 226
2023 Q2 9.67M $892M -$61.9M $92.16 236
2023 Q1 10.2M $1.06B +$86.8M $103.67 262
2022 Q4 9.4M $1.08B -$11.6M $115.35 272
2022 Q3 9.51M $1.03B -$59.2M $108.36 244
2022 Q2 9.68M $1.75B -$24.6M $180.51 271
2022 Q1 9.92M $1.7B +$17.1M $170.78 279
2021 Q4 9.77M $2.05B -$48.3M $209.43 293
2021 Q3 9.99M $1.93B -$28M $192.64 288
2021 Q2 9.96M $2.82B +$76.7M $282.98 295
2021 Q1 9.73M $2.06B -$49.6M $211.82 269
2020 Q4 10M $1.96B -$25.6M $196.34 260
2020 Q3 10.1M $1.66B -$331M $164.45 239
2020 Q2 12.2M $1.69B -$24.8M $138.77 224
2020 Q1 12.4M $776M -$71.6M $62.50 191
2019 Q4 13.3M $1.46B +$25.7M $109.58 212
2019 Q3 13.1M $1.36B +$135M $103.63 233
2019 Q2 11.6M $1.49B -$15.2M $128.30 247
2019 Q1 11.9M $1.52B +$79.9M $127.55 243
2018 Q4 11.3M $1.42B +$13.2M $125.02 240
2018 Q3 10.9M $2.42B +$107M $221.55 266
2018 Q2 10.5M $1.69B -$6.4M $160.16 249
2018 Q1 10.7M $999M +$28.4M $93.45 215
2017 Q4 10.5M $736M +$9.59M $69.81 196
2017 Q3 10.4M $616M -$10.7M $59.37 168
2017 Q2 10.7M $443M -$12.7M $41.47 159
2017 Q1 11M $486M +$77.7M $44.37 165
2016 Q4 10.5M $438M +$8.33M $41.63 158
2016 Q3 10.3M $389M +$4.9M $37.79 160
2016 Q2 10.2M $340M +$2.08M $33.27 150
2016 Q1 10.2M $309M +$17.8M $30.19 128
2015 Q4 9.65M $293M +$9.87M $30.38 125
2015 Q3 9.35M $251M -$24.5M $26.86 117
2015 Q2 10.2M $328M -$6.69M $32.32 125
2015 Q1 10.3M $309M +$4.09M $29.97 123
2014 Q4 10.2M $341M -$1.7M $33.55 125
2014 Q3 10.2M $336M -$68.8M $32.83 127
2014 Q2 12.5M $379M -$4.63M $30.41 134
2014 Q1 12.6M $368M +$28.6M $29.09 132